Primary ovarian adenocarcinoma developing in ovarian remnant tissue ten years after laparoscopic hysterectomy and bilateral salpingo-oophorectomy for endometriosis

Journal of Minimally Invasive Gynecology

Volumn 14, Issue 6, 2007, Pages 752-757

  Donnez, Olivier ^a   Squifflet, Jean ^a   Marbaix, Etienne ^a   Jadoul, Pascale ^a   Donnez, Jacques ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Bilateral salpingo oophorectomy; Endometriosis; Ovarian cancer; Ovarian remnant syndrome

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CLINICAL EXAMINATION; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INTRAVENOUS PYELOGRAPHY; LAPAROSCOPIC SURGERY; OVARY ADENOCARCINOMA; PELVIC INFLAMMATORY DISEASE; PELVIS; POSTOPERATIVE COMPLICATION; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSVAGINAL ECHOGRAPHY;

ADENOCARCINOMA; ENDOMETRIOSIS; FEMALE; HUMANS; HYSTERECTOMY, VAGINAL; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PELVIC PAIN; POSTOPERATIVE COMPLICATIONS;

EID: 35548955020     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2007.05.005     Document Type: Article

References (41)

1. Shemwell R.E., and Weed J.C. Ovarian remnant syndrome. Obstet Gynecol 36 (1970) 299-303
2. Elkins T.E., Stocker R.J., Key D., McGuire E.J., and Roberts J.A. Surgery from ovarian remnant syndrome: lessons learned from difficult cases. J Reprod Med 39 (1994) 446-448
3. Symmonds R.E., and Pettit P.D. Ovarian remnant syndrome. Obstet Gynecol 54 (1979) 174-177
4. Nezhat C.H., Seidman D.S., Nezhat F.R., Mirmalek S.A., and Nezhat C.R. Ovarian remnant syndrome after laparoscopic oophorectomy. Fertil Steril 74 (2000) 1024-1028
5. Mazzeo F., Berlière M., Kerger J., et al. Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol 90 (2003) 163-169
6. Minke T., Depond D., Winkelman T., and Blythe J. Ovarian remnant syndrome: study in laboratory rats. Am J Obstet Gynecol 171 (1994) 1440-1444
7. Nezhat C., Kearney S., Malik S., Nezhat C., and Nezhat F. Laparoscopic management of ovarian remnants. Fertil Steril 83 (2005) 973-976
8. Magtibay P., Nyholm J., Hernandez J., and Podratz K. Ovarian remnant syndrome. Am J Obstet Gynecol 193 (2005) 2062-2066
9. Webb M. Ovarian remnant syndrome. Aus N Z J Obstet Gynaecol 29 (1989) 433-435
10. Steege J. Ovarian remnant syndrome. Obstet Gynecol 70 (1987) 64-67
11. Glaser D., Burrig K., and Mast H. Ovarian cancer in ovarian remnant syndrome?. Gebutshilfe Frauenheilkd 52 (1992) 436-437
12. Narayansingh G., Cumming G., Parkin D., and Miller I. Ovarian cancer developing in the ovarian remnant syndrome. A case report and review of the literature. N Z J Obstet Gynaecol 40 (2000) 221-223
13. Fueyo J., Garces J., Soriano J., Coll J., and Rubies-Prat J. Adenocarcinoma of the ovary in the ovarian remnant. Rev Clini Esp 186 (1990) 415-416
14. Bruhwiler J., and Luscher K. Ovarian cancer in the ovarian remnant syndrome. Gebutshilfe Frauenheilkd 51 (1991) 70-71
15. Kazadi Buanga J., Laparte Escorza M.C., and Lopez Garcia G. Ovarian remnant syndrome. A case report of a malignancy. J Gynecol Obstet Biol Reprod 21 (1992) 769-772
16. Dereska N., Cornella J., Hibner M., and Magrina J. Mucinous adenocarcinoma in an ovarian remnant. Int J Gynecol Cancer 14 (2004) 683-686
17. Melin A., Sparen P., Persson I., and Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Human Reprod 21 (2006) 1237-1242
18. Ness R. Endometriosis and ovarian cancer: Thoughts on shared pathophysiology. Am J Obstet Gynecol 189 (2003) 280-294
19. Fukunaga M., Nomura K., Ishikawa E., and Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 30 (1997) 249-255
20. Oral E., Ilvan S., Tustas E., Korbeyli B., Bese T., Demirkiran F., Arvas M., and Kosebay D. Prevalence of endometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol 109 (2003) 97-101
21. Ness R., Cramer W., Goodman M., et al. Infertility, drugs and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155 (2002) 217-224
22. Brinton L., Gridley G., Persson I., Baron J., and Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176 (1997) 572-579
23. Lauchlan S. The secondary mullerian system revisited. Int J Gynecol Pathol 13 (1994) 73-79
24. Sampson J. Endometrial carcinoma of the ovary. Arising in endometrial tissue in hat organ. Arch Surg 10 (1925) 1-72
25. Seidman J. Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 15 (1996) 1-9
26. Nishida M., Watanabe K., Sato N., and Ishikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest 50 (2000) 18-25
27. Heaps J., Nieberg R., and Berek J. Malignant neoplasms arising in endometriosis. Obstet Gynecol 75 (1990) 1023-1028
28. LaGrenade A., and Silverberg S. Ovarian tumors associated with atypical endometriosis. Human Pathol 19 (1988) 1080-1084
29. Liotta L., and Kohn E. The microenvironment of the tumor-host interface. Nature 411 (2001) 375-379
30. Hanahan D., and Weinberg R. The hallmarks of cancer. Cell 100 (2000) 57-70
31. Varma R., Rollason T., Gupta J., and Maher R. Endometriosis and the neoplastic process. Reproduction 127 (2004) 293-304
32. Somigliana E., Vigano P., and Vercellini P. A literature review of clinical and epidemiological studies addressing the risk of cancer in endometriosis. World Endom Soc e-J 8 (2006) 5-9
33. Erzen M., Rakar S., Klancnik B., and Syrjanen K. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other carcinomas as suggested by a nested case-control study. Gynecol Oncol 83 (2001) 100-108
34. Perez-Garcia J.L., and Carrasco E.M. Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: systematic review of the literature and implications for future research. Gynecol Oncol 84 (2002) 201-209
35. Brinton L., Sakoda L., Sherman M., et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 14 (2005) 2929-2935
36. Yoshikawa H., Jimbo H., Okada S., et al. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50 (2000) 11-17
37. Modesitt S., Tortolero-Luna G., Robinson J., Gershenson D., and Wolf J. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 100 (2002) 788-795
38. Riman T., Dickman P., Nilsson S., et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94 (2002) 497-504
39. Rodriquez C., Patel A., Calle E., Jacob E., and Thun M. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 285 (2001) 460-465
40. Lacey J., Lubin J., Sherman M., Schatzkin A., Mink P., and Hartge P. Menopausal replacement therapy and risk of ovarian cancer in a prospective study. JAMA 288 (2002) 334-341
41. Cramer D., and Missmer S. The epidemiology of endometriosis. Ann N Y Acad Sci 955 (2002) 11-22